| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Effects of intracoronary infusion of peripheral blood stem-cells mobilised with granulocyte-colony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction: the MAGIC cell randomised clinical trial.
|
Lancet
|
2004
|
4.16
|
|
2
|
Synergistic neovascularization by mixed transplantation of early endothelial progenitor cells and late outgrowth endothelial cells: the role of angiogenic cytokines and matrix metalloproteinases.
|
Circulation
|
2005
|
3.54
|
|
3
|
Multicenter randomized trial evaluating the efficacy of cilostazol on ischemic vascular complications after drug-eluting stent implantation for coronary heart disease: results of the CILON-T (influence of CILostazol-based triple antiplatelet therapy ON ischemic complication after drug-eluting stenT implantation) trial.
|
J Am Coll Cardiol
|
2011
|
2.64
|
|
4
|
Increased risk of atherothrombotic events associated with cytochrome P450 3A5 polymorphism in patients taking clopidogrel.
|
CMAJ
|
2006
|
2.01
|
|
5
|
Optimal intravascular ultrasound criteria and their accuracy for defining the functional significance of intermediate coronary stenoses of different locations.
|
JACC Cardiovasc Interv
|
2011
|
1.94
|
|
6
|
Forkhead transcription factor FOXO3a is a negative regulator of angiogenic immediate early gene CYR61, leading to inhibition of vascular smooth muscle cell proliferation and neointimal hyperplasia.
|
Circ Res
|
2007
|
1.89
|
|
7
|
Physiological evaluation of the provisional side-branch intervention strategy for bifurcation lesions using fractional flow reserve.
|
Eur Heart J
|
2008
|
1.84
|
|
8
|
Noninvasive diagnosis of ischemia-causing coronary stenosis using CT angiography: diagnostic value of transluminal attenuation gradient and fractional flow reserve computed from coronary CT angiography compared to invasively measured fractional flow reserve.
|
JACC Cardiovasc Imaging
|
2012
|
1.73
|
|
9
|
Identification of a novel role of T cells in postnatal vasculogenesis: characterization of endothelial progenitor cell colonies.
|
Circulation
|
2007
|
1.71
|
|
10
|
Clinical and physiological outcomes of fractional flow reserve-guided percutaneous coronary intervention in patients with serial stenoses within one coronary artery.
|
JACC Cardiovasc Interv
|
2012
|
1.62
|
|
11
|
Effect of celecoxib on restenosis after coronary angioplasty with a Taxus stent (COREA-TAXUS trial): an open-label randomised controlled study.
|
Lancet
|
2007
|
1.58
|
|
12
|
The effect of stem cell mobilization by granulocyte-colony stimulating factor on neointimal hyperplasia and endothelial healing after vascular injury with bare-metal versus paclitaxel-eluting stents.
|
J Am Coll Cardiol
|
2006
|
1.51
|
|
13
|
Mechanism of edge restenosis after drug-eluting stent implantation. Angulation at the edge and mechanical properties of the stent.
|
Circ J
|
2013
|
1.41
|
|
14
|
Assessment of the bioequivalence of brand and biogeneric formulations of abciximab for the treatment of acute coronary syndrome: a prospective, open-label, randomized, controlled study in Korean patients.
|
Clin Ther
|
2009
|
1.38
|
|
15
|
Involvement of E-selectin in recruitment of endothelial progenitor cells and angiogenesis in ischemic muscle.
|
Blood
|
2007
|
1.27
|
|
16
|
Celecoxib, a cyclooxygenase-2 inhibitor, reduces neointimal hyperplasia through inhibition of Akt signaling.
|
Circulation
|
2004
|
1.21
|
|
17
|
Integrin-linked kinase, a hypoxia-responsive molecule, controls postnatal vasculogenesis by recruitment of endothelial progenitor cells to ischemic tissue.
|
Circulation
|
2006
|
1.18
|
|
18
|
Beta-catenin overexpression reduces myocardial infarct size through differential effects on cardiomyocytes and cardiac fibroblasts.
|
J Biol Chem
|
2006
|
1.15
|
|
19
|
Nitinol spring rod dynamic stabilization system and Nitinol memory loops in surgical treatment for lumbar disc disorders: short-term follow up.
|
Neurosurg Focus
|
2007
|
1.13
|
|
20
|
Comparison of the load-sharing characteristics between pedicle-based dynamic and rigid rod devices.
|
Biomed Mater
|
2008
|
1.12
|
|
21
|
Differential effect of intracoronary infusion of mobilized peripheral blood stem cells by granulocyte colony-stimulating factor on left ventricular function and remodeling in patients with acute myocardial infarction versus old myocardial infarction: the MAGIC Cell-3-DES randomized, controlled trial.
|
Circulation
|
2006
|
1.11
|
|
22
|
Beta-catenin overexpression augments angiogenesis and skeletal muscle regeneration through dual mechanism of vascular endothelial growth factor-mediated endothelial cell proliferation and progenitor cell mobilization.
|
Arterioscler Thromb Vasc Biol
|
2005
|
1.10
|
|
23
|
Peroxisome proliferator-activated receptor-delta agonist enhances vasculogenesis by regulating endothelial progenitor cells through genomic and nongenomic activations of the phosphatidylinositol 3-kinase/Akt pathway.
|
Circulation
|
2008
|
1.09
|
|
24
|
Intercellular adhesion molecule-1 is upregulated in ischemic muscle, which mediates trafficking of endothelial progenitor cells.
|
Arterioscler Thromb Vasc Biol
|
2006
|
1.05
|
|
25
|
Akt is a key modulator of endothelial progenitor cell trafficking in ischemic muscle.
|
Stem Cells
|
2007
|
1.04
|
|
26
|
FOXO3a turns the tumor necrosis factor receptor signaling towards apoptosis through reciprocal regulation of c-Jun N-terminal kinase and NF-kappaB.
|
Arterioscler Thromb Vasc Biol
|
2007
|
1.03
|
|
27
|
Impact of myocardial infarct proteins and oscillating pressure on the differentiation of mesenchymal stem cells: effect of acute myocardial infarction on stem cell differentiation.
|
Stem Cells
|
2008
|
0.99
|
|
28
|
New mechanism of rosiglitazone to reduce neointimal hyperplasia: activation of glycogen synthase kinase-3beta followed by inhibition of MMP-9.
|
Arterioscler Thromb Vasc Biol
|
2009
|
0.98
|
|
29
|
Priming with angiopoietin-1 augments the vasculogenic potential of the peripheral blood stem cells mobilized with granulocyte colony-stimulating factor through a novel Tie2/Ets-1 pathway.
|
Circulation
|
2009
|
0.97
|
|
30
|
Forkhead factor, FOXO3a, induces apoptosis of endothelial cells through activation of matrix metalloproteinases.
|
Arterioscler Thromb Vasc Biol
|
2007
|
0.96
|
|
31
|
Nitric oxide-induced apoptosis is mediated by Bax/Bcl-2 gene expression, transition of cytochrome c, and activation of caspase-3 in rat vascular smooth muscle cells.
|
Clin Chim Acta
|
2004
|
0.94
|
|
32
|
Functional polymorphism in the promoter region of the gelatinase B gene in relation to coronary artery disease and restenosis after percutaneous coronary intervention.
|
J Hum Genet
|
2002
|
0.92
|
|
33
|
Effects of acute hyperglycemia on endothelium-dependent vasodilation in patients with diabetes mellitus or impaired glucose metabolism.
|
Endothelium
|
2003
|
0.91
|
|
34
|
Safety and efficacy of a novel hyperaemic agent, intracoronary nicorandil, for invasive physiological assessments in the cardiac catheterization laboratory.
|
Eur Heart J
|
2013
|
0.89
|
|
35
|
Regulation of endothelial cell and endothelial progenitor cell survival and vasculogenesis by integrin-linked kinase.
|
Arterioscler Thromb Vasc Biol
|
2005
|
0.89
|
|
36
|
The essential role of p21 in radiation-induced cell cycle arrest of vascular smooth muscle cell.
|
J Mol Cell Cardiol
|
2004
|
0.88
|
|
37
|
Comparison of hyperemic efficacy between central and peripheral venous adenosine infusion for fractional flow reserve measurement.
|
Circ Cardiovasc Interv
|
2012
|
0.88
|
|
38
|
Paclitaxel- versus sirolimus-eluting stents for treatment of ST-segment elevation myocardial infarction: with analyses for diabetic and nondiabetic subpopulation.
|
JACC Cardiovasc Interv
|
2010
|
0.88
|
|
39
|
Benefit of complete revascularization in patients with multivessel coronary disease in the drug-eluting stent era.
|
Circ J
|
2012
|
0.88
|
|
40
|
Sulfasalazine induces haem oxygenase-1 via ROS-dependent Nrf2 signalling, leading to control of neointimal hyperplasia.
|
Cardiovasc Res
|
2009
|
0.85
|
|
41
|
Relationship between fractional flow reserve and angiographic and intravascular ultrasound parameters in ostial lesions: major epicardial vessel versus side branch ostial lesions.
|
JACC Cardiovasc Interv
|
2012
|
0.84
|
|
42
|
Long-term clinical outcome of chronic total occlusive lesions treated with drug-eluting stents: comparison of sirolimus-eluting and paclitaxel-eluting stents.
|
Circ J
|
2010
|
0.83
|
|
43
|
Multi-spatial-frequency and phase-shifting profilometry using a liquid crystal phase modulator.
|
Appl Opt
|
2012
|
0.82
|
|
44
|
Stent-related cardiac events after non-cardiac surgery: drug-eluting stent vs. bare metal stent.
|
Int J Cardiol
|
2007
|
0.82
|
|
45
|
Five-year results of intracoronary infusion of the mobilized peripheral blood stem cells by granulocyte colony-stimulating factor in patients with myocardial infarction.
|
Eur Heart J
|
2012
|
0.82
|
|
46
|
Analysis of potential cost-savings after introduction of drug-eluting balloon angioplasty for in-stent restenosis or small vessel disease.
|
Korean Circ J
|
2011
|
0.81
|
|
47
|
Evaluation of local flow conditions in jailed side branch lesions using computational fluid dynamics.
|
Korean Circ J
|
2011
|
0.81
|
|
48
|
Comparison of drug-eluting versus bare-metal stent implantation in ST-elevation myocardial infarction patients with renal insufficiency: results from the national registry in Korea.
|
Int J Cardiol
|
2010
|
0.80
|
|
49
|
NF-kappaB decoy potentiates the effects of radiation on vascular smooth muscle cells by enhancing apoptosis.
|
Exp Mol Med
|
2005
|
0.79
|
|
50
|
Thalidomide as a potent inhibitor of neointimal hyperplasia after balloon injury in rat carotid artery.
|
Arterioscler Thromb Vasc Biol
|
2004
|
0.79
|
|
51
|
Optimal intravascular ultrasound criteria for defining the functional significance of intermediate coronary stenosis: an international multicenter study.
|
Cardiology
|
2014
|
0.79
|
|
52
|
Common adrenergic receptor polymorphisms as novel risk factors for vasospastic angina.
|
Am Heart J
|
2006
|
0.78
|
|
53
|
Cotreatment with darbepoetin and granulocyte colony-stimulating factor is efficient to recruit proangiogenic cell populations in patients with acute myocardial infarction.
|
Cell Transplant
|
2012
|
0.77
|
|
54
|
Efficacies of the new paclitaxel-eluting Coroflex Please stent in percutaneous coronary intervention; comparison of efficacy between Coroflex Please and Taxus (ECO-PLEASANT) trial: study rationale and design.
|
Trials
|
2009
|
0.75
|
|
55
|
The association between the T102C polymorphism of the HTR2A serotonin receptor gene and HDL cholesterol level in Koreans.
|
J Biochem Mol Biol
|
2005
|
0.75
|
|
56
|
Diagnostic value of myocardial SPECT to detect in-stent restenosis after drug-eluting stent implantation.
|
Int J Cardiovasc Imaging
|
2012
|
0.75
|
|
57
|
A vertical-field-driven polymer-stabilized blue phase liquid crystal mode to obtain a higher transmittance and lower driving voltage.
|
Opt Express
|
2011
|
0.75
|
|
58
|
The recanalization of chronic total occlusion leads to lumen area increase in distal reference segments in selected patients: an intravascular ultrasound study.
|
JACC Cardiovasc Interv
|
2012
|
0.75
|
|
59
|
Long-term outcome of adjunctive celecoxib treatment after paclitaxel-eluting stent implantation for the complex coronary lesions: two-year clinical follow-up of COREA-TAXUS trial.
|
Circ Cardiovasc Interv
|
2010
|
0.75
|
|
60
|
Assessment of clinical, electrocardiographic, and physiological relevance of diagonal branch in left anterior descending coronary artery bifurcation lesions.
|
JACC Cardiovasc Interv
|
2012
|
0.75
|
|
61
|
Physiologic evaluation of myocardial bridging: a new analysis for an old disease.
|
Can J Cardiol
|
2011
|
0.75
|
|
62
|
Novel index of coronary collateral development as a useful predictor of clinical outcome in type 2 diabetic patients with coronary artery disease.
|
Circ J
|
2005
|
0.75
|
|
63
|
Comparison of antiplatelet effect and safety of clopidogrel napadisilate with clopidogrel bisulfate in coronary artery disease patients: multi-center, randomized, double-blind, phase IV, non-inferiority clinical trial.
|
Am J Cardiovasc Drugs
|
2013
|
0.75
|